Following the Omnibus IV article, we remind you that Commission Regulation (EU) 2021/1902, the so-called Omnibus IV Regulation, enters into force on the 1st of March 2022. Thus, from now on, only compliant products can be placed on the market and made available on the market. A market withdrawal of non-compliant products must be organized […]
EU
As you probably already know (or as you surely already noticed), the safety, quality, efficacy and labeling requirements are regulated differently in various regions of the world and in some countries, a notification to the National Competent Authorities is required. As an example, a notification (or registration) is mandatory in the following countries: Europe UK […]
With global demand for Korean cosmetics growing, compliance with different countries’ cosmetic regulations is becoming increasingly important. In effect, regulatory compliance in multiple countries is no longer optional but mandatory for global cosmetic brands. Following this trend, KOTRA Brussels and BIORIUS are holding a joint webinar for Korean cosmetic brands on March 10th, 2021. Dr. […]
Introduction In part 1 I explained why finished cosmetics products are not exempted from REACH regulation obligations, particularly from the registration. The main message was that every component of your finished cosmetic product is “registrable” individually. In part 2, I will explain in more detail what needs to be registered, who has to register, and […]
Hydroxyethylmethacrylate (HEMA) and Di-HEMA Trimethylhexyl Dicarbamate (Di-HEMA TMHDC) are two colorless viscous liquids that readily polymerize when exposed to UV-light. Because of their physical properties, these monomers are typically used in nail enhancement products. The skin sensitization potential of these cosmetic ingredients raised concerns since 2016. The restriction of HEMA and Di-HEMA TMHDC to professional […]
The WHO defines an endocrine disruptor as ‘an exogenous substance or mixture that alters function(s) of the endocrine system and consequently causes adverse health effects in an intact organism, or its progeny, or (sub)populations’. This definition has been retained by the European Union, which started a number of developments to better regulate these substances in […]
‘Omnibus Regulation 2019’ : Update December 13th, 2019 As estimated below, the Omnibus Regulation 2019 has been published and we invite you to consult the legal text EU No 2019/1966. The main (if not unique) impact of this new Regulation on the cosmetic industry concerns the use of Salicylic Acid and its salts. Furthermore, the transition period […]
